PHAT

Phathom Pharmaceuticals Inc

$7.58

0.00 (0.00%) Today

0.22 (2.99%) Pre-market

— up— down

Market Cap

$595M-35.0%

Revenue (TTM)

$228.25M+110.2%

Net Income (TTM)

$-101,686,024

$-101,686,024

EPS (TTM)

-1.27

-1.27

Shares Out

79.76M

79.76M

Forward P/E

26.91

26.91

Open

$7.36

$7.36

Previous Close

$7.36

$7.36

Day Range

$7.19 – $7.45

$7.19 – $7.45

52-Week Range

$6.91 – $18.31

$6.91 – $18.31

Beta

0.60

0.60

Volume

657.19K

657.19K

Avg Volume

1.29M

1.29M

Analyst Rating

Buy

Buy

Exchange

NASDAQ NMS - GLOBAL MARKET

NASDAQ NMS - GLOBAL MARKET

About PHAT

Related

News

Phathom Pharmaceuticals Announces Initiation of Registrational Phase 3 Study of VOQUEZNA® (vonoprazan) for As-Needed Treatment of Non-Erosive GERD

Yahoo · 1d ago

Phathom Pharmaceuticals Initiates Registrational Phase 3 Study Of VOQUEZNA For As-Needed Treatment Of Non-Erosive GERD

Benzinga · 1d ago